Table 4.
Clones and clonal-related serotypes of 28 canine multidrug resistant (MDR) E. coli isolates. Prevalence of the canine clones and clone-related serotypes among E. coli isolates causing extraintestinal infections in humans [3,21,62].
Clone of Canine MDR Isolates | Clone-Related Serotype of Canine MDR Isolates (Number of Isolates) | Type of ESBL and pAmpC Enzymes Produced by Canine MDR Isolates | Number of Human E. coli Isolates with Same Clone of Canine MDR Isolates (Number and Type ESBL Produced by Human Isolates) (35 of 394) | Number of Human E. coli Isolates with Same Clone and Serotype of Canine MDR Isolates (1 of 394) |
---|---|---|---|---|
A-CH11-54-ST10 | O128:HNM (1) | SHV12 | 10 (3 SHV12) | 0 |
A-CH11-NEG-ST93 | O5:H4 (1) | none | 4 (1 CTX-M-14) | 0 |
A-CH11-54-ST8953 | O101:HNM (1) | CMY-2 | 0 | 0 |
A-CH11-27-ST new 1 | O4:H27 (1) | none | 0 | 0 |
B1-CH4-27-ST58 | O8:H25 (1), O9:H25 (1) | none | 4 (1 CTX-M-14 and 1 CTX-M-32) | 1 |
B1-CH4-121-ST155 | O5:H11 (1) | none | 0 | 0 |
B1-CH4-366-ST155 | O9:H10 (1) | CMY-2 | 1 (1 CTX-M-1) | 0 |
B1-CH4-425-ST new 15 | O123:H11 (1) | CTX-M-1 | 0 | 0 |
B1-CH4-31-ST new 16 | O8:H7 (1) | CTX-M-1 | 0 | 0 |
B1-CH29-38-ST new 17 | O8:H49 (1) | CTX-M-1 | 0 | 0 |
B1-CH30-38-ST new 18 | O12:H8 (1) | CMY-2 | 0 | 0 |
B2-CH13-223-ST12 | O18:H5 (1) | CMY-2 | 1 | 0 |
B2-CH13-429-ST new 3 | O4:H5 (1) | CMY-2 | 0 | 0 |
C-CH4-39-ST88 | O45:HNM (1) | CTX-M-1 | 11 (1 CTX-M-14) | 0 |
D-CH26-5-ST38 | O86:H18 (3) | CTX-M-14 | 0 | 0 |
D-CH26-65-ST38 | O1:H34 (1) | CMY-2 | 2 (1 CTX-M-15) | 0 |
D-CH35-27-ST new 14 | O77:H18 (1) | none | 0 | 0 |
E-CH31-54-ST57 | O27:H40 (1) | CMY-2 | 1 | 0 |
E-CH11-167-ST695 | O99:H38 (1) | none | 0 | 0 |
E-CH4-31-ST1011 | O166:H45 (1) | CTX-M-55 | 0 | 0 |
E-CH23-221-ST1140 | O44:H39 (1) | none | 0 | 0 |
E-CH485-426-ST3774 | O9:H31 (1) | CMY-2 | 0 | 0 |
F-CH88-145-ST457 | O11:H25 (2) | CMY-2 | 0 | 0 |
F-CH4-27-ST648 | O4:H6 (1) | CTX-M-14 | 1 (1 CTX-M-15) | 0 |
Bold highlights those canine clones and serotypes also detected among E. coli isolates causing extraintestinal infections in humans.